✦ LIBER ✦

Labeling of monoclonal antibodies with 153Sm for potential use in radioimmunotherapy

✍ Scribed by M Fani; S Vranjes; S.C Archimandritis; S Potamianos; S Xanthopoulos; P Bouziotis; A.D Varvarigou

Book ID: 108482253
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 161 KB
Volume: 57
Category: Article
ISSN: 0969-8043
DOI: 10.1016/s0969-8043(02)00181-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibodies labeled with 199Au: Potential

Antibodies labeled with 199Au: Potential of 199Au for radioimmunotherapy

✍ Anderson, Philip; Vaughan, Andrew T.M.; Varley, Nicholas R. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 505 KB

Potential labeling of monoclonal antibod

Potential labeling of monoclonal antibodies with positron emitters

✍ Welch, Michael J.; Kilbourn, M.R. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 178 KB

Radiolabeling of monoclonal anti-CD105 w

Radiolabeling of monoclonal anti-CD105 with 177Lu for potential use in radioimmunotherapy

✍ Lee, So-Young; Hong, Young-Don; Felipe, Penelope M.; Pyun, Mi-Sun; Choi, Sun-Ju 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Radioimmunotherapy for Pancreatic Carcin

Radioimmunotherapy for Pancreatic Carcinoma Using131I-Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice

✍ Inui, Akimasa ;Chung, Yong-Suk ;Sawada, Tetsuji ;Kondo, Yasuyuki ;Ho, Jenny J. L 📂 Article 📅 1996 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 568 KB

An effective chelating agent for labelli

An effective chelating agent for labelling of monoclonal antibody with 212Bi for ?-particle mediated radioimmunotherapy

✍ Brechbiel, Martin W.; Pippin, C. Greg; McMurry, Thomas J.; Milenic, Diane; Rosel 📂 Article 📅 1991 🏛 The Royal Society of Chemistry 🌐 English ⚖ 282 KB

Antiangiogenic radioimmunotherapy of hum

Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using 125I-labeled anti-endoglin monoclonal antibodies

✍ Masahiro Tabata; Masao Kondo; Yuro Haruta; Ben K. Seon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 162 KB

Endoglin (CD105), which is a component of the TGF-␤ receptor complex, is highly expressed at the surface of proliferating human endothelial cells such as those of tumor vessels. In the present study, we tested the antitumor efficacy of 125 I-labeled anti-endoglin monoclonal antibodies (MAbs), SN6f a